ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2020 American Transplant Congress

    Factors Associated with Hepatocellular Carcinoma Understaging for Liver Transplantation, and Variation in Understaging by Transplant Center

    N. Mahmud1, M. Hoteit1, D. Goldberg2

    1Hospital of the University of Pennsylvania, Philadelphia, PA, 2University of Miami, Miami, FL

    *Purpose: Hepatocellular carcinoma (HCC) may be cured by liver transplantation (LT) in selected patients, though recurrence rates remain high. Patients who are reported as within…
  • 2020 American Transplant Congress

    Financial Feasibility of a Culturally Competent and Linguistically Congruent Hispanic Kidney Transplant Program

    E. Gordon1, A. Wang1, G. McNatt1, M. Abecassis2, J. Caicedo1

    1Northwestern U Feinberg Sch of Medicine, Chicago, IL, 2University of Arizona, Tuscon, AZ

    *Purpose: Relative to their representation on the waitlist, Hispanics/Latinos received significantly fewer LDKTs than non-Hispanic Whites in 2018: 5.0% versus 12.2%. In 2006, Northwestern Medicine…
  • 2020 American Transplant Congress

    Outcomes and Health Care Utilization after Early Hospital Dismissal in Kidney Transplantation: An Analysis of 1001 Consecutive Cases

    E. Calderon1, Y. Chang2, J. M. Chang1, C. Velazco1, E. Giorgakis1, A. A. Moss1, H. Khamash3, R. Heilman3, K. S. Reddy1, A. K. Mathur1

    1Transplant Surgery, Mayo Clinic, Phoenix, AZ, 2Kern Center for the Science of Health Care Delivery, Mayo Clinic, Phoenix, AZ, 3Department of Nephrology, Mayo Clinic, Phoenix, AZ

    *Purpose: Perioperative care after kidney transplantation has improved with reduction in length of operative stay to as low as two days, but this has an…
  • 2020 American Transplant Congress

    Identification of Novel Gene Targets Inducing Resistance in Liver Ischemia Reperfusion Injury by CRISPR Screening

    C. Kuscu, A. R. Wolen, C. Kuscu, C. Watkins, A. Bajwa, J. D. Eason, D. Maluf, V. Mas

    Dept of Surgery, Transplant Research Institute, James D. Eason Transplant Institute, University of Tennessee Health Science Center, Memphis, TN

    *Purpose: Liver transplantation (LT) is the best treatment option for patients with end-stage liver disease (ESLD). However, the gap between available donors and recipients in…
  • 2020 American Transplant Congress

    Autophagy-Lysosome Inhibitor Chloroquine Prevents CTLA-4 Degradation of T Cells and Attenuates Acute Rejection in Murine Skin and Heart Transplantation

    J. Wu

    Department of Cardiovascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

    *Purpose: The immune checkpoint cytotoxic T lymphocyte antigen-4 (CTLA-4), which was induced upon T cell activation but degraded quickly, has been targeted in the clinical…
  • 2020 American Transplant Congress

    Steroid Withdrawal and Lymphocyte Subsets in Graft Capillary Blood versus Peripheral Blood in Low Immunological Risk Kidney Transplant Patients: Randomized, Parallel Group, Controlled Clinical Trial

    T. Vazquez Sanchez, A. Caballero, J. Alonso-Titos, V. Lopez, E. Sola, M. Cabello, E. Gutierrez Vilchez, M. Martínez-Esteban, P. Ruiz Esteban, J. Delgado, D. Hernandez

    Regional University Hospital, Malaga, Spain

    *Purpose: Whether steroid withdrawal can modulate the subclinical inflammatory response after a kidney transplant is unknown.*Methods: We undertook a controlled multicenter clinical trial involving 105…
  • 2020 American Transplant Congress

    Three-Month Results of a Phase 2 Trial Evaluating Clazakizumab in Late Antibody-Mediated Rejection – Early Impact of Interleukin-6 Blockade on Donor-Specific Antibody Levels, Rejection Morphology and Gene Expression

    G. A. Böhmig1, M. Dürr2, B. Jilma3, F. Eskandary1, E. Chong4, S. Schranz3, K. Doberer1, M. Wahrmann1, A. Borski1, H. Regele5, J. Kläger5, R. Reindl-Schwaighofer1, J. Reeve6, K. Budde2, P. F. Halloran6

    1Department of Medicine III, Medical University of Vienna, Vienna, Austria, 2Nephrology Department, Charité Berlin, Berlin, Germany, 3Dept. of Clin. Pharmacology, Medical University of Vienna, Vienna, Austria, 4Vitaeris Inc., Vancouver, BC, Canada, 5Dept. of Clin. Pathology, Medical University of Vienna, Vienna, Austria, 6Alberta Transplant Applied Genomics Centre, ATAGC, University of Alberta, Edmonton, AB, Canada

    *Purpose: Targeting Interleukin-6 (IL-6) is a promising strategy to counteract antibody-mediated rejection (ABMR). This phase 2 trial (NCT03444103) was designed to evaluate the safety and…
  • 2020 American Transplant Congress

    Does Choice of Inferior Vena Cava Reconstruction Technique Have an Impact on the Short and Long Term Postoperative Renal Function in Liver Transplant Recipient?

    S. Chartier-Plante1, S. Asrani2, J. Bayer2, H. Fernandez2, A. Gupta2, E. Martinez2, G. J. Mckenna2, N. Onaca2, N. Onaca2, R. M. Ruiz2, G. Saracino2, A. Wall2, G. Testa2

    1Vancouver General Hospital, Vancouver, BC, Canada, 2Baylor University Medical Center, Dallas, TX

    *Purpose: Postoperative acute kidney injury (AKI) is common after liver transplant (Oltx). It is associated with increased morbidity and mortality and is a risk factor…
  • 2020 American Transplant Congress

    Impact of Frailty on Early and Late Hospital Readmission after Kidney Transplantation

    H. Hendra1, B. Sandhu2, E. Frackiewicz2, G. Jones2, P. Masson2, R. Motallebzadeh3

    1Centre for Transplantation, Department of Renal Medicine, University College London & Royal Free London NHS Foundation Trust, London, United Kingdom, 2Royal Free Hospital, London, United Kingdom, 3Centre for Transplantation, University College London & Royal Free London NHS Foundation Trust, London, United Kingdom

    *Purpose: Currently there are no tools to predict outcomes after kidney transplantation (KTx). This study assesses whether frailty influences post-KTx complications. Understanding frailty and its…
  • 2020 American Transplant Congress

    Effect of DSA-Free Heart Allocation

    V. Patel1, M. Skeans2, T. Cascino1, R. Davies3, M. Colvin1

    1University of Michigan, Ann Arbor, MI, 2SRTR, Minneapolis, MN, 3UT Southwestern, Dallas, TX

    *Purpose: Currently, donation service area (DSA) is the first geographic unit for heart allocation, which creates discrepancies in access for high-urgency candidates. We studied the…
  • « Previous Page
  • 1
  • …
  • 147
  • 148
  • 149
  • 150
  • 151
  • …
  • 223
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences